X0508 4 2024-01-05 false 0001314102 EyePoint Pharmaceuticals, Inc. EYPT 0001904458 Pine Michael Craig 480 PLEASANT ST, STE A210 WATERTOWN MA 02472 false true false false Chief Corp Dev.&Strat. Officer false Common Stock 2024-01-06 4 M false 15285.00 0.00 A 19628.00 D Common Stock 2024-01-06 4 F false 5966.00 20.40 D 13662.00 D Restricted Stock Units 0.00 2024-01-05 4 A false 21000.00 0.00 A 2034-01-05 Common Stock 21000.00 21000.00 D Stock Option (Right to Buy) 20.40 2024-01-05 4 A false 42000.00 0.00 A 2034-01-04 Common Stock 42000.00 42000.00 D Restricted Stock Units 0.00 2024-01-06 4 M false 15285.00 0.00 D 2033-06-19 Common Stock 15285.00 30570.00 D No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units The restricted stock units will vest in three ratable annual installments beginning January 5, 2025. The option to purchase will vest and become exercisable as follows: 25% at January 5th, 2025 and the remainder ratably, on a monthly basis, over the remaining three years. The restricted stock units vests in three ratable annual installments beginning January 6, 2024. /s/ Ron Honig, Attorney-in-Fact 2024-01-09